Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’

Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’

September 1, 2026Posted inMedical Technology

Boston Scientific has told its customers to stop using its Imager II angiographic catheters upon learning that a manufacturing issue has impacted the tips of the devices.

Post navigation

Previous Post
Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response
Next Post
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots

Recent Posts

  • Alumis crushed by midstage lupus flop but plots path to phase 3 for TYK2 inhibitor
  • Novocure hit by cyberattack exposing patient data
  • GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
  • Boston Scientific halts sales of angiographic catheters amid ‘two serious injuries’
  • Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top